Neuphoria Therapeutics (NEUP) Financial Statements

300 Followers

Neuphoria Therapeutics Financial Overview

Neuphoria Therapeutics's market cap is currently $23.62M. The company's EPS TTM is $; its P/E ratio is -0.86; Neuphoria Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 25	Jun 24	Jun 23	Jun 22	Jun 21
Income Statement
Total Revenue	AU$ 15.65M	AU$ 0.00	AU$ 0.00	AU$ 383.16K	AU$ 0.00
Gross Profit	AU$ 15.65M	AU$ -662.99K	AU$ -671.48K	AU$ 383.16K	AU$ 0.00
Operating Income	AU$ -1.13M	AU$ -26.79M	AU$ -33.09M	AU$ -31.02M	AU$ -8.96M
EBITDA	AU$ -121.90K	AU$ -25.65M	AU$ -31.45M	AU$ -30.25M	AU$ -4.51M
Net Income	AU$ -369.63K	AU$ -23.19M	AU$ -32.18M	AU$ -31.62M	AU$ -6.53M
Balance Sheet
Cash & Short-Term Investments	AU$ 21.59M	AU$ 12.61M	AU$ 8.06M	AU$ 33.56M	AU$ 21.41M
Total Assets	AU$ 43.44M	AU$ 27.65M	AU$ 19.39M	AU$ 65.30M	AU$ 40.77M
Total Debt	AU$ 226.49K	AU$ 272.74K	AU$ 257.55K	AU$ 693.55K	AU$ 652.04K
Net Debt	AU$ -21.37M	AU$ -12.34M	AU$ -7.80M	AU$ -32.87M	AU$ -20.76M
Total Liabilities	AU$ 14.57M	AU$ 10.16M	AU$ 4.74M	AU$ 8.40M	AU$ 5.01M
Stockholders' Equity	AU$ 28.87M	AU$ 17.49M	AU$ 14.65M	AU$ 56.91M	AU$ 35.76M
Cash Flow
Free Cash Flow	AU$ 77.23M	AU$ -14.68M	AU$ -9.85M	AU$ -21.75M	AU$ -5.67M
Operating Cash Flow	AU$ 77.23M	AU$ -14.68M	AU$ -9.85M	AU$ -21.75M	AU$ -5.66M
Investing Cash Flow	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 621.64K	AU$ -60.26K
Financing Cash Flow	AU$ 1.53B	AU$ 15.11M	AU$ 2.60M	AU$ 26.99M	AU$ 23.71M

Currency in AUD

Neuphoria Therapeutics Earnings and Revenue History

Income Statement >

Neuphoria Therapeutics Debt to Assets

Balance Sheet >

Neuphoria Therapeutics Cash Flow

Cash Flow >

Neuphoria Therapeutics Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >